LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION

K Fuhrlinger; Daniela Kniepeiss; Harald Heinrich Schrem; Zoltan Mathe; Peter Schemmer; Helmut Müller; Florian Iberer; K Tscheliessnigg

LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION

K Fuhrlinger
, Daniela Kniepeiss
, Harald Heinrich Schrem
, Zoltan Mathe
, Peter Schemmer
, Helmut Müller
, Florian Iberer
, K Tscheliessnigg

Division of General, Visceral and Transplant Surgery

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Transplant International
Publication status	Published - 2019
Event	28. Jahrestagung der Deutschen Transplantationsgesellschaft - Hannover, Germany Duration: 17 Oct 2019 → 19 Oct 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

302 Clinical Medicine
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences

Links

Web of Science

LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION
Fuhrlinger, K. (Author), Kniepeiss, D. (Author), Schrem, H. H. (Author), Mathe, Z. (Author), Schemmer, P. (Author), Müller, H. (Author), Iberer, F. (Author) & Tscheliessnigg, K. (Author)
2019
Activity: Talk, presentation or poster › Scientific talk or presentation › On site

Cite this

@article{f1c6771fb3074964a2a9861b35305220,

title = "LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION",

author = "K Fuhrlinger and Daniela Kniepeiss and Schrem, \{Harald Heinrich\} and Zoltan Mathe and Peter Schemmer and Helmut M{\"u}ller and Florian Iberer and K Tscheliessnigg",

year = "2019",

language = "English",

journal = "Transplant International",

issn = "0934-0874",

publisher = "Frontiers Media SA",

note = "28. Jahrestagung der Deutschen Transplantationsgesellschaft, DTG 28 ; Conference date: 17-10-2019 Through 19-10-2019",

}

TY - JOUR

T1 - LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION

AU - Fuhrlinger, K

AU - Kniepeiss, Daniela

AU - Schrem, Harald Heinrich

AU - Mathe, Zoltan

AU - Schemmer, Peter

AU - Müller, Helmut

AU - Iberer, Florian

AU - Tscheliessnigg, K

PY - 2019

Y1 - 2019

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000490006000066

M3 - Conference abstract

SN - 0934-0874

JO - Transplant International

JF - Transplant International

T2 - 28. Jahrestagung der Deutschen Transplantationsgesellschaft

Y2 - 17 October 2019 through 19 October 2019

ER -

LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION

UN SDGs

Branches of science

Links

Activities

LOW-DOSE ATG HAS NO INFLUENCE ON PATIENT SURVIVAL, GRAFT SURVIVAL AND CANCER-FREE SURVIVAL AND IMPROVES RENAL OUTCOME IN PATIENTS WITH COMPROMISED KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION

Cite this